Gentian Diagnostics ASA announced that Tomas Settevik, the Chairperson of the Board, has chosen not to stand for re-election. Tomas has been instrumental in guiding the board and the company. All the announced changes will take effect as of April 29, 2024, subject to the approval by the General Meeting.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
40.2 NOK | -1.47% | +6.91% | -3.13% |
Apr. 30 | Gentian Diagnostics ASA Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 30 | Transcript : Gentian Diagnostics ASA, Q1 2024 Earnings Call, Apr 30, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.13% | 56.85M | |
-9.59% | 7.67B | |
+1.67% | 5.41B | |
+8.69% | 4.62B | |
+0.02% | 4.57B | |
-51.89% | 3.22B | |
+6.42% | 2.59B | |
-13.56% | 2.05B | |
-8.29% | 1.79B | |
+1.67% | 1.76B |
- Stock Market
- Equities
- GENT Stock
- News Gentian Diagnostics
- Tomas Settevik Not to Stand for Re-Election as Chairperson of Gentian Diagnostics ASA, Effective April 29, 2024